Answers are grounded in this paper and cite their sources.
Introduction We assessed the feasibility and cognitive effects of a ketogenic diet (KD) in participants with Alzheimer's disease. Methods The Ketogenic Diet Retention and Feasibility Trial featured a 3‐month, medium‐chain triglyceride–supplemented KD followed by a 1‐month washout in clinical dementia rating (CDR) 0.5, 1, and 2 participants. We obtained urine acetoacetate, serum β‐hydroxybutyrate, food record, and safety data. We administered the Alzheimer's Disease Assessment Scale‐cognitive subscale and Mini–Mental State Examination before the KD, and following the intervention and washout. Results We enrolled seven CDR 0.5, four CDR 1, and four CDR 2 participants. One CDR 0.5 and all CDR 2 participants withdrew citing caregiver burden. The 10 completers achieved ketosis. Most adverse events were medium‐chain triglyceride–related. Among the completers, the mean of the Alzheimer's Disease Assessment Scale‐cognitive subscale score improved by 4.1 points during the diet ( P = .02) and reverted to baseline after the washout. Discussion This pilot trial justifies KD studies in mild Alzheimer's disease.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: